Multispectroscopic and Theoretical Investigation on the Binding Interaction of a Neurodegenerative Drug, Lobeline with Human Serum Albumin: Perturbation in Protein Conformation and Hydrophobic–Hydrophilic Surface
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Vibeizonuo Rupreo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology Nagaland, Chumukedima, Nagaland 797103, India. Hauptthemen laut MEDLINE: Hydrophobic and Hydrophilic Interactions, Protein Binding, Serum Albumin, Human, Lobeline. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Defence Research and Development Organisation, S. N. Bose National Centre for Basic Sciences.
Abstract (Originalsprache)
Lobeline (LOB), a naturally occurring alkaloid, has a broad spectrum of pharmacological activities and therapeutic potential, including applications in central nervous system disorders, drug misuse, multidrug resistance, smoking cessation, depression, and epilepsy. LOB represents a promising compound for developing treatments in various medical fields. However, despite extensive pharmacological profiling, the biophysical interaction between the LOB and proteins remains largely unexplored. In the current article, a range of complementary photophysical and cheminformatics methodologies were applied to study the interaction mechanism between LOB and the carrier protein HSA. Steady-state fluorescence and fluorescence lifetime experiments confirmed the static-quenching mechanisms in the HSA-LOB system. "K" (binding constant) of the HSA-LOB system was determined to be 105 M-1, with a single preferable binding site in HSA. The forces governing the HSA-LOB stable complex were analyzed by thermodynamic parameters and electrostatic contribution. The research also investigated how various metal ions affect complex binding. Site-specific binding studies depict Site I as probable binding in HSA by LOB. We conducted synchronous fluorescence, 3D fluorescence, and circular dichroism studies to explore the structural alteration occurring in the microenvironment of amino acids. To understand the robustness of the HSA-LOB complex, we used theoretical approaches, including molecular docking and MD simulations, and analyzed the principal component analysis and free energy landscape. These comprehensive studies of the structural features of biomolecules in ligand binding are of paramount importance for designing targeted drugs and delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National Institute of Technology Nagaland, Chumukedima, Nagaland 797103, India.
- Department of Chemical & Biological Sciences, National Institute of Technology Meghalaya, Shillong 793003, India.
ORCID-Profile: Atanu Singha Roy, Jhimli Bhattacharyya
Förderung
- Defence Research and Development Organisation
- S. N. Bose National Centre for Basic Sciences
Zitieren
APA
Rupreo, V., Tissopi, R., Baruah, K., Roy, A. S., & Bhattacharyya, J. (2024). Multispectroscopic and Theoretical Investigation on the Binding Interaction of a Neurodegenerative Drug, Lobeline with Human Serum Albumin: Perturbation in Protein Conformation and Hydrophobic–Hydrophilic Surface. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00651
Vancouver
Rupreo V, Tissopi R, Baruah K, Roy AS, Bhattacharyya J. Multispectroscopic and Theoretical Investigation on the Binding Interaction of a Neurodegenerative Drug, Lobeline with Human Serum Albumin: Perturbation in Protein Conformation and Hydrophobic–Hydrophilic Surface. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00651
BibTeX
@article{Rupreo2024,
author = {Rupreo, Vibeizonuo and Tissopi, Rengka and Baruah, Kakali and Roy, Atanu Singha and Bhattacharyya, Jhimli},
title = {Multispectroscopic and Theoretical Investigation on the Binding Interaction of a Neurodegenerative Drug, Lobeline with Human Serum Albumin: Perturbation in Protein Conformation and Hydrophobic–Hydrophilic Surface},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00651}
}
EUVIMED